Skip to content
Home/Companies/Pharma/Orsini Pharmaceutical Services

Orsini Pharmaceutical Services

Pharma·Japan·Active
Entry
–
Hold
–
Status
Active

Who owns Orsini Pharmaceutical Services?

Orsini Pharmaceutical Services is a Japanese Pharma company, currently owned by The Carlyle Group.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
The Carlyle Group
Investor
The Carlyle Group
Carlyle Japan · 2022 · Growth

Key facts

HQJapan
SectorPharma

More from Carlyle Japan

Other portfolio companies in the same fund.

CureApp Inc.
CureApp Inc.
Active
HealthTechJapan
Kyoden Co., Ltd.
Active
IndustrialsJapan
Money Square Holdings, Inc.
Exited 2022
FintechJapan
to Neusynergy Capital Management / Nojima vehicle
Orion Breweries, Ltd.
Orion Breweries, Ltd.
Active
ConsumerJapan
Oyatsu Company Limited
Exited 2022
ConsumerJapan
to D Capital
Psychiatric Medical Care
Active
HealthcareJapan

More PE-backed in Pharma

Comparable pharma deals from other GPs.

AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Active
Cathay CapitalFrance

Questions

Who owns Orsini Pharmaceutical Services?

Orsini Pharmaceutical Services is currently owned by The Carlyle Group, through Carlyle Japan.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue